(Q37742178)

22 August 2017

1 reference

title

In vitro susceptibility testing in Aspergillus species: an update (English)

1 reference

22 August 2017

Aspergillus

1 reference

1

Cornelia Lass-Flörl

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

22 August 2017

volume

5

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

789-799

1 reference

Therapeutic outcome in invasive aspergillosis

22 August 2017

cites work

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Caspofungin in the treatment of candidosis and aspergillosis

21 January 2018

1 reference

Fungal infections in cancer patients: an international autopsy survey.

21 January 2018

1 reference

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

21 January 2018

1 reference

Antifungal drug resistance of pathogenic fungi.

21 January 2018

1 reference

What is a species in Aspergillus?

21 January 2018

1 reference

Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus

21 January 2018

1 reference

Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

21 January 2018

1 reference

Antifungal drug resistance in Aspergillus

21 January 2018

1 reference

Antifungal susceptibility testing

21 January 2018

1 reference

Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi

21 January 2018

1 reference

In vitro susceptibility-testing in Aspergillus species

21 January 2018

1 reference

Azole-resistance in Aspergillus: proposed nomenclature and breakpoints

21 January 2018

1 reference

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

21 January 2018

1 reference

Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.

21 January 2018

1 reference

Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods

21 January 2018

1 reference

Analysis of growth characteristics of filamentous fungi in different nutrient media.

21 January 2018

1 reference

Analysis of the influence of Tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp

21 January 2018

1 reference

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

21 January 2018

1 reference

Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans

21 January 2018

1 reference

Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli

21 January 2018

1 reference

Antimicrobial susceptibility testing of six clinical isolates of Aspergillus

21 January 2018

1 reference

Caspofungin: the first in a new class of antifungal agents

21 January 2018

1 reference

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

21 January 2018

1 reference

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

21 January 2018

1 reference

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

21 January 2018

1 reference

Utility of mould susceptibility testing

21 January 2018

1 reference

Has antifungal susceptibility testing come of age?

21 January 2018

1 reference

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

21 January 2018

1 reference

Acquired itraconazole resistance in Aspergillus fumigatus

21 January 2018

1 reference

Azole-resistant central nervous system aspergillosis.

21 January 2018

1 reference

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

21 January 2018

1 reference

Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.

21 January 2018

1 reference

In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole

21 January 2018

1 reference

Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

21 January 2018

1 reference

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

21 January 2018

1 reference

Disseminated Aspergillus terreus infection in immunocompromised hosts.

21 January 2018

1 reference

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

21 January 2018

1 reference

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.

21 January 2018

1 reference

In vitro susceptibility testing in fungi: a global perspective on a variety of methods

21 January 2018

1 reference

In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing

21 January 2018

1 reference

Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?

21 January 2018

1 reference

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

21 January 2018

1 reference

Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida

21 January 2018

1 reference

In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method

21 January 2018

1 reference

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

21 January 2018

1 reference

Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration

21 January 2018

1 reference

Effects of serum on in vitro susceptibility testing of echinocandins

21 January 2018

1 reference

Antifungal susceptibility testing: practical aspects and current challenges

21 January 2018

1 reference

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

21 January 2018

1 reference

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species

21 January 2018

1 reference

Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin

21 January 2018

1 reference

Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi

21 January 2018

1 reference

Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

21 January 2018

1 reference

Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole

21 January 2018

1 reference

Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.

21 January 2018

1 reference

Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus

21 January 2018

1 reference

In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.

21 January 2018

1 reference

Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species

21 January 2018

1 reference

Antifungal susceptibility testing by flow cytometry: is it the future?

21 January 2018

1 reference

Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole

21 January 2018

1 reference

Conidial viability assay for rapid susceptibility testing of Aspergillus species

21 January 2018

1 reference

Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining

21 January 2018

1 reference

Potential basis for amphotericin B resistance in Aspergillus terreus

21 January 2018

1 reference

Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.

21 January 2018

1 reference

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

21 January 2018

1 reference

Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillu

21 January 2018

1 reference

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro

21 January 2018

1 reference

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions

21 January 2018

1 reference

Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods

21 January 2018

1 reference

Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.

21 January 2018

1 reference

Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.

21 January 2018

1 reference

Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole

21 January 2018

1 reference

Azole cross-resistance in Aspergillus fumigatus

21 January 2018

1 reference

Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.

21 January 2018

1 reference

Multidrug resistance in Aspergillus fumigatus.

21 January 2018

1 reference

In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species

21 January 2018

1 reference

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

21 January 2018

1 reference

Triazole-resistant candidaemia following posaconazole exposure

21 January 2018

1 reference

First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Outwitting multidrug resistance to antifungals

21 January 2018

1 reference

Multidrug resistance in fungi

21 January 2018

1 reference

Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study

21 January 2018

1 reference

Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study

21 January 2018

1 reference

Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.

21 January 2018

1 reference

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

21 January 2018

1 reference

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.

21 January 2018

1 reference

Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology

21 January 2018

1 reference

Antifungal susceptibility testing inAspergillusspp. according to EUCAST methodology

21 January 2018

1 reference

Multi-azole resistance in Aspergillus fumigatus

21 January 2018

1 reference

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.10.34

1 reference

22 August 2017

1 reference